Banner 2 copy

                                                                                                                                                   Our Team   |   PublicationsPresentations   |   Contact Us                                             Home

           Presentations

           Alan F. Kaul   Vinit P. Nair |     Cheryl A. Stoukides

Alan F. Kaul

Pharm.D., M.S. M.B.A, F.C.C.P

1. Comparing hypercholesterolemia management by payor types.POSTER: Academy of Managed Care Pharmacy 1997 Educational Conference. Seattle, WA, October 31, 1997

2. Pharmacy at the Millennium: Pharmacists and Disease Management. Continuing Education Talk, Huntsville Marriot Hotel, Huntsville, AL. Tuesday, March 23, 1999

3. Developing Clinical Guidelines and Their Legal Implications. Washington Metropolitan Area Society of Health-System Pharmacists Continuing Education Program, Bethesda, MD November 16,2000

4. Clinical and Economic outcomes in the Thrombolytic Treatment of Peripheral Vascular Occlusion. with Ouriel K and Katzen BT. Society of Interventional Radiology, March 30, 2003, Salt Late City

5. Differentiating Thrombolytic Agents: Clinical Differentiation and Pharmacoeconomic Considerations. Presented with SR Deitcher and MR Jaff as a series of 25 Telepoint Conferences web and voice conferences for physicians and pharamcists April -June 2003

6. Clinical and Economic outcomes in the Thrombolytic treatment of Peripheral Vascular Occlusion with Leonard MC, Ouriel K, and Katzen BT. American College of Clinical Pharmacy Meeting, Atlanta, November 3, 2003 [abstract]

7. Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Analysis of Clarithromycin Extended Release vx. Azithromycin. with Castaldo RS, Cifaldi M, Mato P, Castaldo A, Chopko M, Peterson B. Chest 2003 Annual International Scientific Assembly October 29, 2003. Orlando FL

8. Thrombolytic therapy versus anticoagulation for treatment of deep vein thrombosis: 10-year clinical observation. With P Thorpe and RJ Bosch, 2004 29th Annual Scientific Meeting,. Society of Interventional Radiology. Phoenix, AZ March 26, 2004.

9. Integrating Disease State Management and Economics, Academy of Managed Care Pharmacy, Baltimore, MD; October 14, 2004. DOWNLOAD

10. Economic Modeling as a Disease Management Tool, Academy of Managed Care Pharmacy, Denver, CO, April 21st 2005. DOWNLOAD

11. Practical Guide to Disease Management, Academy of Managed Care Pharmacy, Nashville, TN, October 6, 2005. DOWNLOAD

Vinit P. Nair

B.Pharm., M.S., R.Ph.

1. Estimation of Hepatotoxic Drug Use and Outcomes in Managed Care as a Medication Error Reduction Strategy, Academy of Managed Care Pharmacy, San Francisco, CA, April 2004. DOWNLOAD

2. Integrating Disease State Management and Economics, Academy of Managed Care Pharmacy, Baltimore, MD; October 14, 2004. DOWNLOAD

3. Economic Modeling as a Disease Management Tool, Academy of Managed Care Pharmacy, Denver, CO; April 21st  2005. DOWNLOAD

4. Practical Guide to Disease Management, Academy of Managed Care Pharmacy, Nashville, TN, October 6, 2005. DOWNLOAD

Cheryl A, Stoukides

Pharm.D.,B.C.P.S, R.Ph.

1. Implementing a Disease State Management Program. California Society of Hospital Pharmacists. SEMINAR '96, Anaheim, CA. October 20, 1996

2. The Effects of Payor Types on Managing Hypercholesterolemia. A Round Table Discussion. The Academy of Managed Care Pharmacy 1997 Educational Conference. Seattle, WA. November 1, 1997
 
3. Proton Pump Inhibitor Therapy: Preliminary Results of a Therapeutic Interchange Program. The Academy of Managed Care Pharmacy 1999 Educational Conference. Atlanta, GA. October 8, 1999

 

 

BannerBottom03 copy0202